Search Results

Site Search

MayoComplete next-generation sequencing: Transforming comprehensive cancer care - Insights

Offering increased sensitivity and improved accuracy, MayoComplete next-generation testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions to guide their care.

Alzheimer's Disease Testing - Mayo Clinic Laboratories

We have developed an innovative evaluation for Alzheimer's disease, which uses CSF biomarkers to achieve a high concordance with amyloid PET scan.

MCL Familial Chromosomal Microarray FISH Testing Information MC1235236

MCL Familial Chromosomal Microarray FISH Testing Information Family Member Phenotype Information Genomic Testing Instructions accurate interpretation reporting familial genetic results highly contingent

thrombophilia_profile.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. AATHR / Thrombophilia Profile, Plasma and Whole Blood Testing begins with: ■ Prothrombin Time (PT), Plasma ■ Activated Partial Thromboplastin Time (APTT),...

GeoBioMed: How geologic rock formations inform novel treatments for kidney stones - Part I - Insights

A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.

MCL Rare Coagulation Disorder Patient Information MC1235264

MCL Rare Coagulation Disorder Patient Information Complete print Reset Form Rare Coagulation Disorder Patient Information Instructions Genetic testing rare hereditary disorders blood coagulation

Preeclampsia - Insights

Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.

https://news.mayocliniclabs.com/file-activity-metrics-user-guide/

Activity Metrics User’s Guide Release 1.21 Page 2 9/26/24 Activity Metrics User’s Guide TABLE OF CONTENTS Introduction...

Precision medicine for obesity program - Insights

PACE/State of CA/State of FL - In this month’s “Virtual Lecture,” Andres Acosta, M.D., Ph.D., discusses how individualized medicine can play a role in obesity.

MCL Von Willebrand Disease Patient Information MC1235265

MCL Von Willebrand Disease Patient Information Complete print Reset Form von Willebrand Disease Patient Information Instructions von Willebrand factor VWF gene testing von Willebrand